Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bonkovsky

Showing results (271-280 of 351) with videos related to

Pageof 36
Sort By:
Journal of Immunotoxicology|January 26, 2017
Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune responseJessica Whritenour, Mira Ko, Qing Zong, et al.
European Journal of Clinical Investigation|May 9, 2013
Circadian rhythms in acute intermittent porphyria--a pilot studySebastian Larion, Frederick R Caballes, Sun-Il Hwang, et al.
Gastroenterology|October 10, 1997
Utility of hepatic iron index in American patients with hereditary hemochromatosis: a multicenter studyK V Kowdley, T D Trainer, J R Saltzman, et al.
Journal of Viral Hepatitis|May 11, 2012
Antigen-specific T lymphocyte proliferation decreases over time in advanced chronic hepatitis CC Morishima, A M Di Bisceglie, A L Rothman, et al.
Journal of Hepatology|July 21, 2023
Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trialDavid J Kuter, Herbert L Bonkovsky, Susana Monroy, et al.
Hepatology Communications|August 8, 2019
Genetic Polymorphisms Implicated in Nonalcoholic Liver Disease or Selected Other Disorders Have No Influence on Drug-Induced Liver InjuryHerbert L Bonkovsky, Tyler Severson, Paola Nicoletti, et al.
Plos One|July 16, 2011
An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis CThomas R O'Brien, James E Everhart, Timothy R Morgan, et al.
Journal of Hepatology|July 16, 2008
DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trialTimothy R Morgan, Richard W Lambrecht, Herbert L Bonkovsky, et al.
Clinical Chemistry|October 21, 2015
Pitfalls in Erythrocyte Protoporphyrin Measurement for Diagnosis and Monitoring of ProtoporphyriasEric W Gou, Manisha Balwani, D Montgomery Bissell, et al.
Journal of Proteomics|September 3, 2010
Discovery of putative pancreatic cancer biomarkers using subcellular proteomicsKimberly Q McKinney, Yong-Yook Lee, Hyun-Su Choi, et al.
Pageof 36

Showing results (271-280 of 351) with videos related to

Sort By:
Pageof 36
Journal of Immunotoxicology|January 26, 2017
Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune responseJessica Whritenour, Mira Ko, Qing Zong, et al.
European Journal of Clinical Investigation|May 9, 2013
Circadian rhythms in acute intermittent porphyria--a pilot studySebastian Larion, Frederick R Caballes, Sun-Il Hwang, et al.
Gastroenterology|October 10, 1997
Utility of hepatic iron index in American patients with hereditary hemochromatosis: a multicenter studyK V Kowdley, T D Trainer, J R Saltzman, et al.
Journal of Viral Hepatitis|May 11, 2012
Antigen-specific T lymphocyte proliferation decreases over time in advanced chronic hepatitis CC Morishima, A M Di Bisceglie, A L Rothman, et al.
Journal of Hepatology|July 21, 2023
Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trialDavid J Kuter, Herbert L Bonkovsky, Susana Monroy, et al.
Hepatology Communications|August 8, 2019
Genetic Polymorphisms Implicated in Nonalcoholic Liver Disease or Selected Other Disorders Have No Influence on Drug-Induced Liver InjuryHerbert L Bonkovsky, Tyler Severson, Paola Nicoletti, et al.
Plos One|July 16, 2011
An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis CThomas R O'Brien, James E Everhart, Timothy R Morgan, et al.
Journal of Hepatology|July 16, 2008
DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trialTimothy R Morgan, Richard W Lambrecht, Herbert L Bonkovsky, et al.
Clinical Chemistry|October 21, 2015
Pitfalls in Erythrocyte Protoporphyrin Measurement for Diagnosis and Monitoring of ProtoporphyriasEric W Gou, Manisha Balwani, D Montgomery Bissell, et al.
Journal of Proteomics|September 3, 2010
Discovery of putative pancreatic cancer biomarkers using subcellular proteomicsKimberly Q McKinney, Yong-Yook Lee, Hyun-Su Choi, et al.
Pageof 36